Type 1 diabetes: open trials in Argentina

• NCT07784725

  A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  Trial Treatment · Phase 3 · AstraZeneca

  Buenos Aires · Ciudad de Buenos Aires · Mendoza · Ramos Mejía · Rosario · San Nicolás

  Registry updated 2026-10-30

• NCT07088068

  A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  Trial Treatment · Phase 3 · Sanofi

  Buenos Aires · Córdoba · Mar del Plata · Salta · San Miguel de Tucumán · Santa Fe

  Registry updated 2026-10-13

• NCT07564414

  A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  OMI- Organización Médica de Investigación, Buenos Aires · Hospital Sirio Libanes, Buenos Aires · Kynet Recoleta, Buenos Aires · Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli, Buenos Aires · Cedic - Centro de Investigacion Clinica, CABA · Centro Médico Viamonte SRL, CABA · CIPREC Arenales, CABA · CEMEDIC, CABA · Centro de Investigaciones Metabólicas, Capital Federal · CICEMO- Consultorio (Av Directorio), Ciudad Autónoma de Buenos Aires · Centro Médico Arsema, Ciudad Autónoma de Buenos Aires · Instituto Centenario, Ciudad de Buenos Aires · Centro de Investigación C.I.C.E 9 de Julio - Sanatorio 9 de Julio, San Miguel de Tucumán · CEDIR - Centro de diagnóstico y rehabilitación Santa Fe, Santa Fe · Sanatorio Norte, Santiago del Estero

  Registry updated 2026-09-30

• NCT07776509

  A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  Trial Treatment · Phase 3 · AstraZeneca

  Buenos Aires · CABA · Ciudad de Buenos Aires · Ramos Mejía · Rosario · San Nicolás

  Registry updated 2026-09-25

• NCT07797335

  AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Instituto de Investigaciones Clínicas Bahia Blanca, Bahía Blanca · Hospital Sirio Libanes, Buenos Aires · OMI- Organización Médica de Investigación, Buenos Aires · Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli, Buenos Aires · Centro Médico Viamonte SRL, CABA · CEMEDIC, CABA · CENUDIAB Centro Médico de Nutrición v Diabetes, CABA · CIPREC Arenales, CABA · Fundacion Respirar, Ciudad Autonoma de Buenos Aires · Dolz Investigacion Clinica, Ciudad Autónoma de Buenos Aires · Centro Diabetologico Cordoba Dr. Waitman, Córdoba · Centro Medico Privado CEMAIC, Córdoba · CIPADI, Godoy Cruz · Centro de Investigaciones Medicas Mar Del Plata, Mar del Plata · Fundacion Estudios Clinicos, Rosario · Nuvexa, Rosario · Centro Oncologico de Excelencia (COE), San Juan · Clínica Mayo de Urgencias Médicas Cruz Blanca, San Miguel de Tucumán · CIMRO, San Rafael

  Registry updated 2026-09-01

• NCT07621419

  Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin

  Research · Hospital Italiano de Buenos Aires

  Hospital General de Agudos Dr Enrique Tornú, Buenos Aires · Hospital Italiano de Buenos Aires, Buenos Aires

  Registry updated 2026-06-02

All Type 1 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error